BioNTech SE (BNTX) Short-Term Debt to Capital
BioNTech SE (BNTX) is steadily expanding its influence thanks to the diplomatic neutrality of medicine. The ratio of short-term borrowed capital to equity confirms financial stability, with the parameter reaching 0.01. BioNTech SE (BNTX) relies on breakthrough mRNA technologies that are transforming cancer therapy. The business foundation consists of powerful patents and massive cash reserves generated from vaccine sales.
Metric breakdowns and analytics for biontech.de (BNTX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:BioNTech Group, BNTX
Liquidity control is critical for BioNTech SE (BNTX) given its volatile post-pandemic revenues. This metric is calculated as the ratio of liabilities maturing within one year to total equity. By analyzing the historical trend of short-term loans relative to equity, an investor assesses the company's ability to service its debt without external refinancing. An upward trend in the curve signals a default risk should there be delays in the commercialization of new oncology drugs.
Competing companies
Argenx (ARGX) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Abivax S.A. (ABVX)|Short-Term Debt to Capital ADMA (ADMA Biologics)|protagonist-inc.com - Short-Term Debt to Capital|Short-Term Debt to Equity Immunovant (IMVT)|KNSA: Ratio of Short-Term Indebtedness to Capital|GRFS (Grifols Group) - Short-Term Debt to Equity|Adaptive Biotechnologies Inc. (ADPT) - Short-Term Debt to Equity Ratio|CLDX (Celldex Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Vera Therapeutics Inc (VERA)|Short-Term Debt to Capital DNTH|Pharvaris Pharma - Short-Term Debt to Capital Coefficient|ABCL: Short-Term Debt to Equity|TRML: Short-Term Debt to Equity Ratio|PGEN (Precigen) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|NKTR (Nektar) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital UPB|Short-Term Debt to Equity Zenas Biopharma Inc ZBIO|Short-Term Debt to Capital Ratio immunome.com (IMNM)|GOSS: Short-Term Debt to Capital|Current Liabilities to Capital KalVista Pharma KALV|SEPN - Short-Term Debt to Capital|PVLA - Short-Term Debt to Equity|Savara Inc. - Short-Term Debt to Capital|RIGL (rigel.com) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity ANAB (AnaptysBio)|Current Liabilities to Capital ATXS|Short-Term Debt to Equity enGene Bio ENGN|Short-Term Debt to Capital Ratio rapt.com RAPT|Short-Term Debt to Equity Ratio Aerovate Therapeutics (JBIO)|Short-Term Loans to Capital Ratio aclaristx.com ACRS|KYTX (Kyverna Therapeutics, Inc.) - Short-Term Debt to Capital|TLSA - Current Liabilities to Capital|CABA (Cabaletta Bio, Inc) - Short-Term Debt to Capital|Ventyx Biosciences, Inc (VTYX) - Short-Term Debt to Equity Ratio|THTX - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital avalotx.com (AVTX)|Eledon Pharmaceuticals, Inc. (ELDN) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AGEN (Agenus, Inc.)|Short-Term Debt to Equity CLYM|Short-Term Debt to Capital Coefficient zurabio.com ZURA|ATYR (aTyr Pharma, Inc.) - Short-Term Debt to Capital|ADAG - Current Liabilities to Capital|ikenaoncology.com (IMA) - Short-Term Debt to Capital|STTK (Shattuck Labs) - Short-Term Debt to Equity|Short-Term Debt to Equity Equillium Inc (EQ)|Short-Term Debt to Capital Ratio Connect Pharma (CNTB)|Short-Term Debt to Equity Ratio Immunic, Inc.|Short-Term Loans to Capital Ratio atarabio.com ATRA|IFRX - Short-Term Debt to Equity Ratio|X4 Pharmaceuticals Inc. - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity Adicet|CELU - Current Liabilities to Equity|Short-Term Debt to Capital INmune Bio, Inc. INMB|barinthusbio.com (BRNS) - Ratio of Short-Term Indebtedness to Capital|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital SABS|Akari Therapeutics plc (AKTX) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ENLV (enlivex.com)|Q32 Bio - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio geovax.com GOVX|Edesa Biotech - Short-Term Debt to Capital|iBio Inc (IBIO) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio carismatx.com CARM|XTL Bio (XTLB) - Ratio of Short-Term Indebtedness to Capital|BOLT: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient HCWB|Short-Term Debt to Equity APVO (Aptevo Therapeutics)|Short-Term Debt to Equity Ratio AIM (aimimmuno.com)|Aditxt, Inc. - Short-Term Debt to Equity|GRI - Short-Term Debt to Equity Ratio|XORTX Therapeutics Inc. - Short-Term Debt to Equity Ratio|HIND: Short-Term Debt to Capital|Short-Term Debt to Equity Revelation Biosciences, Inc.|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital SCNI (Scinai)|Current Liabilities to Capital CalciMedica Corp|Short-Term Debt to Capital Affimed (AFMD)|Short-Term Debt to Equity allakos.com (ALLK)|Short-Term Debt to Capital HOOK|IGM Biosciences Inc. - Short-Term Debt to Capital Coefficient|ITOS (iTeos) - Short-Term Debt to Equity|OCEA: Current Liabilities to Capital|Short-Term Debt to Equity TC Biopharm|Short-Term Debt to Capital Ratio thirdharmonicbio.com